Search

everythinglearnresearchcommunity

for

Search:↓

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Drug repositioning is a promising way to quickly develop new treatments, especially for rare diseases.

Understanding the Y chromosome is key to male health, aging, and developing diagnostic tools.

MicroRNAs could help assess and manage multiple chronic diseases.

Genetic factors could lead to personalized treatments for hair loss.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Standardized procedures are crucial for collecting and preparing biological samples to ensure accurate clinical metabolomics results.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

Olfactory receptors found outside the nose may offer new treatments for diseases like cancer and help in wound healing and hair growth.

Certain genes and X chromosome patterns may significantly contribute to the development of hair loss.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

People with androgenetic alopecia have a higher risk of heart disease.

A genetic test can identify people at risk of male pattern baldness early, allowing for quicker treatment.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

Eclipta prostrata is a medicinal plant that helps treat diseases, protects the liver and nerves, and promotes hair growth.

Sex hormones affect liver fat and metabolic health differently in men and women.

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.

Prostate cancer is common, but risk can be reduced by avoiding smoking, unhealthy diet, inactivity, certain medications, and risky jobs.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

ERG increases SOX9, promoting prostate cancer growth and invasion.

PSA is best for detecting prostate cancer recurrence and evaluating treatment response.

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.